This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slipped 7.5% to $22.36 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.2% to 22,078.05 and Dow Jones Industrial Average falling 0.8% to 45,752.26.
This was the stock's second consecutive day of losses.
Moderna Inc. closed 54.3% below its 52-week high of $48.92, which the company achieved on January 7th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.3% to $203.07, Pfizer Inc. fell 1.9% to $24.40, and Gilead Sciences Inc. fell 2.40% to $124.99.
Trading volume totaled 18.3 million, compared to the 50-day average of 11.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 20, 2025 16:34 ET (21:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.